Scholar Rock Holding Corporation

Depreciation and amortization expense Scholar Rock is a holding company. Through its subsidiaries, the company is a biopharmaceutical company focused on the discovery and development of innovative medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. The company's lead products include SRK-015, a selective and local inhibitor of latent myostatin activation for the treatment of myopathies.
  • TickerSRRK
  • ISINUS80706P1030
  • ExchangeNASDAQ Stock Market
  • SectorPharmaceuticals & Biotechnology
  • CountryUnited States

Analysts

ValuEngine Rating and Forecast Report for SRRK

ValuEngine Rating and Forecast Report for SRRK

David Nierengarten ...
  • Jeffrey La Rosa

All Eyez on TOPAZ

David Nierengarten ...
  • Jeffrey La Rosa

All Eyez on TOPAZ

ValuEngine Rating and Forecast Report for SRRK

ValuEngine Rating and Forecast Report for SRRK

ValuEngine Rating and Forecast Report for SRRK

ValuEngine Rating and Forecast Report for SRRK

ValuEngine Rating and Forecast Report for SRRK

ValuEngine Rating and Forecast Report for SRRK

ValuEngine Rating and Forecast Report for SRRK

ValuEngine Rating and Forecast Report for SRRK

ValuEngine Rating and Forecast Report for SRRK

ValuEngine Rating and Forecast Report for SRRK

ResearchPool Subscriptions

Get the most out of your insights

Get in touch